Find policies, billing codes, payers, states, and providers
Radiofrequency Facet and Sacroiliac Joint Ablation/ Denervation
Customize your policy alerts
Sign up for univerahealthcare Policy 7.01.42 alerts
Get alerted when Policy 7.01.42 changes without checking for updates manually.
Monitor payer policy activity
Criteria for medical necessity, limits, and investigational determinations for radiofrequency denervation/ablation of facet and sacroiliac joints for cervical, thoracic, and lumbar axial pain; applies to Univera Healthcare plan determinations.
No material clinical or coverage changes in this revision.
Coverage Criteria for Radiofrequency Denervation/Ablation
Initial Therapy
Covered when ALL of the following are met:
All conditions required
Continuation/Repeat Therapy
Covered when ALL of the following are met:
All conditions required for repeat
Covered with criteria
Coverage rules and scope for facet joint RFA
Repeat imaging is not required unless newer symptoms are reported and need evaluation.
Facet RFA — selection/efficacy evidence
Evidence and patient selection considerations reported in the literature excerpts
Documented dual positive blocks cited in RCTs and systematic reviews as predictor of treatment success
Sacroiliac Joint RFA — technique-specific evidence
SIJ RFA evidence synthesis and technique-specific outcomes
Heterogeneity of techniques affects certainty
BVN ablation — evidence summary
Basivertebral nerve (BVN) ablation evidence
Crossover and study design limitations noted; longer-term follow-up demonstrates sustained improvements in many cohorts
Basivertebral Nerve Ablation (BVNA) — Covered Indications
Covered when ALL of the following are met (per NASS/ISASS/ASPN guidance):
NASS recommendation
Guideline-aligned requirement
Selection criterion supported by NASS/ASPN guidance
Sacroiliac Joint Lateral Branch RFA — Covered Indications
Covered when ALL of the following are met (per NASS/ASPN/AAPM consensus):
NASS/ASPN consensus; incomplete diagnostic confirmation risks denial
ASPN and other guidelines recommend prior conservative management
ASPN preferred strategy prior to neuroablative procedures
The following situations are explicitly identified as not medically necessary for facet joint radiofrequency denervation/ablation: procedures performed without the use of CT or fluoroscopic guidance; more than two denervations/ablations at the same level during a rolling 12‑month period (note that a minimum interval of 6 months between denervations is required); procedures done in the presence of untreated radicular pain or radiculopathy; treating more than three contiguous facet joint levels in a single session (unilateral or bilateral) or more than a total of six facet joints bilaterally in the same session; treatment for pain arising above C2‑C3 or below L5‑S1; and performing more than one invasive modality or procedure on the same date of service (for example, combining facet injections, medial branch blocks, epidural steroid injections, or sacroiliac joint injections on the same date).
Facet joint RFA is considered not medically necessary when more than one invasive modality or procedure is performed on the same date of service (e.g., concurrent facet joint injection, medial branch block, epidural steroid injection, or sacroiliac joint injection). Additionally, procedures targeting the L5 medial branch and sacral lateral nerve branches for diagnosis or treatment of SIJ‑mediated pain, and radiofrequency denervation/ablation of the intraosseous basivertebral nerve for vertebrogenic back pain, are specifically excluded from coverage under the facet/SIJ RFA criteria.
A complaint of pain localized over the sacroiliac joint alone, without supporting radicular findings or adequate diagnostic confirmation, does not substantiate a diagnosis of sacroiliac joint (SIJ) pain. Clinical evaluation must include appropriate diagnostic steps rather than relying solely on localized pain to determine SIJ as the pain generator.
Transforaminal epiduroscopic basivertebral nerve (BVN) laser ablation is not supported by the North American Spine Society (NASS) and is identified as a technique that remains investigational and requiring further study; current guidance does not support its routine use.
Coverage determinations and application of this medical policy are product dependent. If a product does not cover a specific service, the medical policy criteria in this document do not apply. Conversely, if a product covers the service and there is no applicable national or local Medicare coverage decision, medical policy criteria apply to benefit determinations per the product rules.
Exclusions summarized elsewhere in this policy are reiterated here: procedures performed without CT or fluoroscopic guidance; exceeding the allowed frequency (more than two denervations at the same level within a rolling 12‑month period or less than the required six‑month interval); treating anatomic levels outside the C2‑C3 to L5‑S1 range; performing more than three contiguous facet levels or more than six facet joints bilaterally in a single session; treating in the presence of untreated radiculopathy; and performing multiple invasive procedures/modalities on the same date of service.
If more than one invasive modality or procedure is performed on the same date of service, facet joint radiofrequency denervation/ablation is considered not medically necessary. This single‑session restriction includes combinations such as diagnostic injections, therapeutic injections, and other invasive interventions performed during the same session.
Pulsed radiofrequency (PRF) denervation is noted to have insufficient evidence. Early studies and systematic reviews indicate limited data and uncertainty about efficacy compared with continuous thermal RF; current literature is inadequate to draw definitive conclusions supporting PRF for facet joint pain.
Ablative techniques with very limited or low‑quality evidence — including cryoablation, intra‑articular chemical neurolysis, and similar approaches for sacroiliac joint pain — are identified as having limited support in the literature and are considered investigational or of uncertain benefit pending higher‑quality evidence.
Coding and Diagnostic Thresholds
| 64451 | Injection(s), anesthetic agent(s), and/or steroid; nerves innervating the sacroiliac joint, with image guidance (i.e., fluoroscopy or computed tomography). (E/I) |
| 64625 | Radiofrequency ablation, nerve innervating the sacroiliac joint, with image guidance (i.e., fluoroscopy or computed tomography). (E/I) |
| 64628 | Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral. (E/I) |
| 64629 | Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; each additional vertebral body, lumbar or sacral. (List separately in addition to code for primary procedure). (E/I) |
| 64633 | Destruction by neurolytic agent, paravertebral facet joint nerves(s) with imaging guidance (fluoroscopy or CT); cervical or thoracic, single facet joint. |
| 64634 | Cervical or thoracic each additional facet joint. |
| 64635 | Lumbar or sacral, single facet joint. |
| 64636 | Lumbar or sacral, each additional facet joint. |
| M47.011-M47.9 | Spondylosis (code range) |
| M54.10-M54.9 | Dorsalgia (code range) |
| No codes listed |
Provider Actions, Documentation, and Prior Authorization
Prior authorization expectation for initial and repeat RFA/BVNA
Initial and repeat radiofrequency denervation/ablation require that all medical necessity criteria in the policy are met (including documented diagnostic blocks, conservative therapy, timing/intervals between procedures, and imaging/clinical findings) and prior authorization is implied by the requirement to meet those documented criteria.
- Includes diagnostic blocks and intervals
- Applies to initial and repeat procedures per policy language
Applicability: facet joint RFA scope
Policy criteria apply to facet joint radiofrequency denervation/ablation performed for facet-mediated cervical, thoracic, or lumbar axial pain. The procedure criteria apply to the facet joint(s) denervated/ablated and not to the number of nerves treated.
Diagnostic medial branch block requirement
Prior diagnostic medial branch/facet joint blocks with documented positive responses are required to identify candidates for RFA; a positive response is defined as at least 80% relief of the facet-mediated pain for at least the expected minimum duration of the local anesthetic used.
- Two sequential positive diagnostic facet joint injections/medial branch blocks at the same level(s) are required
Prior authorization for BVN, SIJ and RF denervation procedures
Prior authorization is recommended/required for procedures and CPT codes related to basivertebral nerve ablation, sacroiliac joint injections, and radiofrequency denervation to ensure device clearance and guideline-based indications are met.
Benefit and prior authorization depend on product coverage
Benefit coverage and application of medical policy criteria are contract dependent; medical policy criteria apply only when the product covers the specific service per the product’s benefit rules.
Conservative therapy required prior to initial RFA
Before an initial facet joint RFA, the member must have persistent pain despite at least four weeks of conservative treatment within the past three months, or the medical record must document a contraindication to conservative therapy.
- Examples of conservative treatment: exercise, physical therapy, chiropractic care, NSAIDs or analgesics
- If contraindicated, the reason must be documented in the medical record
Conservative care requirement before BVN ablation
For basivertebral nerve ablation, trials enrolled patients who failed prior conservative care—typically at least 3 months (pilot studies) or ≥6 months (major trials) of conservative management—and documentation of prior conservative therapy attempts and durations should be provided.
- Document duration of prior nonsurgical management (e.g., ≥3–6 months depending on trial)
- Ensure Modic Type 1 or 2 imaging findings are present when BVNA is considered
Conservative care and diagnostic blockade before SIJ RFA
Preferred guideline recommendations for sacroiliac lateral branch RFA require an appropriate trial of conservative care and response to diagnostic blockade; dual diagnostic blockade (L5 dorsal ramus and S1–S3 sacral lateral branches) with ≥50% improvement in pain and function is the preferred strategy prior to neuroablative procedures.
- ASPN/NASS guidance recommends trial of conservative care before SIJ RFA
- Dual diagnostic blocks with ≥50% improvement preferred
Required documentation for initial RFA
Medical record must document prior conservative therapy (or the reason for contraindication) and two sequential diagnostic facet injections/medial branch blocks at the same level(s) with magnitude and duration of relief recorded (positive response = ≥80% relief for the expected anesthetic duration).
- Record type, dose, timing, and percent pain relief for each diagnostic block
- Document fusion status of the spinal motion segment(s) and any exception rationale
Repeat RFA documentation and timing expectations
For repeat facet joint RFA after a prior successful procedure, additional diagnostic blocks are not required but documentation must show prior benefit (≥50% relief lasting ≥12 weeks) and that the repeat procedure is performed at least 6 months after the prior denervation/ablation.
- Document magnitude and duration of prior relief (≥50% for ≥12 weeks)
- Document timing showing ≥6 months since prior procedure
Procedural and diagnostic documentation requirements
Document the magnitude and duration of diagnostic medial branch/facet joint block responses (percent relief and duration) and include fluoroscopic-guided procedural details (needle placement, electrostimulation, lesioning temperatures) to support medical necessity for RFA.
- Record procedural imaging modality (fluoroscopy/CT) and lesion parameters
- Include electrostimulation findings and needle positioning
Required clinical documentation for BVNA and RFA
Include clinical documentation of chronicity of low back pain (typically ≥6 months when BVNA is considered), prior nonsurgical management attempts, and presence of Modic Type 1 or 2 changes on MRI when BVNA is being considered.
- Document duration of symptoms and prior conservative treatments
- Provide MRI report confirming Modic Type 1 or 2 changes between L3–S1 when applicable
Medicare / LCD note for BVNA
Intraosseous basivertebral nerve ablation is not addressed in national or regional Medicare coverage determinations within this document segment; review applicable LCDs/CMS resources for local coverage guidance.
- CMS LCD L40302 referenced for BVN; check current Medicare coverage determinations
Common triggers for claim/service denial
Denial risk exists if the procedure is performed without CT or fluoroscopic guidance; if more than two denervations/ablations are performed at the same level during a rolling 12‑month period; if performed with untreated radicular pain/radiculopathy; if >3 contiguous facet levels or >6 facet joints bilaterally are treated in the same session; or if more than one invasive modality is performed on the same date of service.
- Procedures must use CT or fluoroscopic guidance
- At least 6 months required between denervations at same level; no more than two denervations at same level during rolling 12 months
- Do not perform >3 contiguous levels or >6 facet joints bilaterally in same session
- Avoid performing multiple invasive modalities on same date of service
Single‑session multiple invasive procedures — denial risk
Facet joint RFA is considered not medically necessary when more than one invasive modality or procedure is performed on the same date of service (e.g., facet injection, medial branch block, epidural steroid injection, sacroiliac injection).
SIJ diagnosis confirmation — denial risk
The presence of pain over the sacroiliac joint without radicular findings alone does not substantiate the diagnosis of SIJ pain; incomplete diagnostic confirmation may lead to denial.
Diagnostic block confirmation — denial risk
A diagnosis of facet joint pain requires documented response to nerve blocks; lack of the required documented diagnostic block responses (two sequential blocks with the threshold described in policy) risks denial of medical necessity.
- Policy notes diagnosis confirmed by response to nerve blocks with at least 50% improvement after required two positive blocks; elsewhere positive response for facet blocks is defined as ≥80% relief for expected anesthetic duration
BVNA indication denial risk without Modic changes
BVN ablation performed without documentation of Modic Type 1 or 2 changes on MRI when BVNA is being considered may not meet evidence-based indications and carries denial risk.
Confirm benefit coverage before authorization/claim submission
Services are contract dependent; if a product does not cover a specific service, medical policy criteria do not apply—confirm member benefit coverage before submitting authorization or claims.
Conservative Treatment and Trial Requirements
Document prior conservative therapy or contraindication — 4 weeks within prior 3 months required
Document conservative therapy or contraindication within the medical record:
Required for initial RFA unless contraindicated
Document prior conservative therapy attempts — duration per trial requirements (3–6 months)
Document prior conservative therapy attempts with trial-duration expectations:
Follow trial-aligned durations for BVNA candidacy
Trial of nonsurgical management required prior to BVNA; conservative care and diagnostic blockade required/preferred before SIJ RFA
Trials and guidelines require nonsurgical management and diagnostic confirmation prior to these neuroablative procedures:
NASS/ASPN/INTRACEPT/SMART trial-aligned requirement
ASPN/NASS/AAPM consensus guidance
Frequency and Procedural Limits
Imaging and Procedural Guidance Requirements
CT or fluoroscopic guidance required for facet RFA
Facet joint radiofrequency denervation/ablation must be performed using CT or fluoroscopic guidance per policy requirements.
Imaging not routinely required for repeat RFA
For repeat facet joint RFA, repeat imaging is not required unless new or worsening symptoms are reported that would prompt reassessment.
Fluoroscopy expected for facet/medial branch RFA
Facet and medial branch radiofrequency procedures are described as performed under fluoroscopic guidance; document fluoroscopic guidance during the procedure.
MRI for BVNA; fluoroscopy/CT guidance intra‑procedure
When BVNA is being considered, obtain MRI demonstrating Modic Type 1 or 2 endplate changes; intra-procedural image guidance for BVNA and facet/SIJ RF should be fluoroscopy or CT.
- MRI required to document Modic Type 1 or 2 changes for BVNA selection
- Use fluoroscopy or CT intra-procedurally for BVNA and RF procedures
Fluoroscopy recommended for sacroiliac interventions
Guidelines and appropriate use criteria reference fluoroscopic guidance for sacroiliac interventions; document use of fluoroscopy for SIJ diagnostic and therapeutic procedures per guideline recommendations.
Definitions
Not Covered / Investigational Procedures
The policy lists several procedures as not covered / investigational, including pulsed radiofrequency ablation, endoscopic radiofrequency denervation and other endoscopic techniques, cryoablation/cryoneurolysis, chemical neurolysis (e.g., alcohol, phenol), laser ablation techniques, and certain SIJ and BVN techniques not supported by guideline bodies. These designations reflect limited or inconsistent evidence and guideline recommendations citing investigational status for these modalities.
Background and Evidence Context
Facet joint radiofrequency denervation/ablation is used to treat facet‑mediated axial pain of the cervical, thoracic, or lumbar spine after conservative management and confirmation by diagnostic medial branch or facet joint injections. Randomized trials and systematic reviews demonstrate that appropriately selected patients — typically those with positive diagnostic blocks — can achieve clinically meaningful pain reduction after thermal RFA, with many trials using thresholds such as ≥50% improvement to define treatment response, and diagnostic block criteria often requiring larger relief (commonly ≥80% relief) to identify candidates.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.